Mr. Damien McCallion:

On the metrics around the delivery, there are a couple of observations in the report. One was the emphasis on time and to ensure that was strengthened up by quality metrics.

Dr. Scally continues in the report to talk about strengthening the quality assurance, QA, piece. I mentioned earlier that we have put a process in place to strengthen the QA process. That is not a simple switch-on process, one has to look at the QA around the laboratories. In future contracts that are put in place with laboratories, we will be addressing that in a much more substantial way. There are metrics there and there is a need, as Dr. Scally said, to enhance these. It also links in the whole way through in terms of quality assurance.